Stock Events

Stock Events

Filana Therapeutics (SAVA) Q2 2024 Earnings

10MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.77

-0.66

-0.54

-0.43

Details

Expected EPS

-0.46

Actual EPS

-0.43

Surprise EPS

0.03

Surprise Percent

+6.52%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.43 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.